Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
3
×
cancer drugs
life sciences
national blog main
san francisco blog main
blueprint medicines
clinical trials
eli lilly
europe blog main
national top stories
roche
san francisco top stories
amgen
avapritinib
black diamond therapeutics
bladder cancer
boston
capmatinib
cobimetinib
deals
deciphera pharmaceuticals
endometral cancer
europe top stories
european society for medical oncology
fda
gastrointestinal stromal tumors
genentech
glioblastoma
indiana blog main
indiana top stories
investing
ipo
life science
loxo oncology
medullary thyroid cancer
mirati therapeutics
new enterprise associates
What
cancer
drug
3
×
medicines
3
×
ipo
research
targets
address
approval
approves
biotech
black
blueprint
carries
certain
clinic
companies
designed
despite
diamond
eluded
family
fda
genetic
hardest
hit
hopes
hottest
hunters
latest
lead
leading
lines
molecular
nears
new
pass
phase
proteins
ras
ready
Language
unset
Current search:
cancer
×
medicines
×
drug
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic